M Klinger

628 total citations
22 papers, 522 citations indexed

About

M Klinger is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, M Klinger has authored 22 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Immunology. Recurrent topics in M Klinger's work include Glycosylation and Glycoproteins Research (3 papers), Renal Diseases and Glomerulopathies (3 papers) and Liver Diseases and Immunity (3 papers). M Klinger is often cited by papers focused on Glycosylation and Glycoproteins Research (3 papers), Renal Diseases and Glomerulopathies (3 papers) and Liver Diseases and Immunity (3 papers). M Klinger collaborates with scholars based in United States, Poland and Germany. M Klinger's co-authors include J. Peter Gergen, Karl Bauer, Perry M. Kirkham, Harry W. Schroeder, Michael Zemlin, Cosima Zemlin, Jeffrey A. Engler, Jason M. Link, Sheldon M. Steiner and Roger A. Laine and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Molecular Biology and Analytical Biochemistry.

In The Last Decade

M Klinger

21 papers receiving 490 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M Klinger United States	7	343	200	138	46	29	22	522
Hennie R. Hoogenboom Netherlands	10	451 1.3×	413 2.1×	154 1.1×	22 0.5×	11 0.4×	11	672
Edward Franklin Ireland	13	271 0.8×	76 0.4×	90 0.7×	26 0.6×	27 0.9×	22	518
Amara C. Siva United States	10	560 1.6×	44 0.2×	173 1.3×	33 0.7×	10 0.3×	12	837
J. R. Kettman United States	11	137 0.4×	129 0.6×	111 0.8×	22 0.5×	16 0.6×	25	363
Charnell I. Sommers United States	13	108 0.3×	90 0.5×	66 0.5×	18 0.4×	24 0.8×	15	360
ZK Indik United States	5	221 0.6×	221 1.1×	239 1.7×	23 0.5×	42 1.4×	8	458
Louis Toujas France	16	250 0.7×	120 0.6×	372 2.7×	34 0.7×	11 0.4×	61	679
Katrijn Broos Belgium	15	337 1.0×	242 1.2×	384 2.8×	70 1.5×	25 0.9×	20	771
Richard Priest United Kingdom	12	210 0.6×	92 0.5×	171 1.2×	24 0.5×	17 0.6×	15	507
Jean-Philippe Gaudry Switzerland	6	264 0.8×	79 0.4×	117 0.8×	31 0.7×	22 0.8×	9	436

Countries citing papers authored by M Klinger

Since Specialization

Citations

This map shows the geographic impact of M Klinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Klinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Klinger more than expected).

Fields of papers citing papers by M Klinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Klinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Klinger. The network helps show where M Klinger may publish in the future.

Co-authorship network of co-authors of M Klinger

This figure shows the co-authorship network connecting the top 25 collaborators of M Klinger. A scholar is included among the top collaborators of M Klinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Klinger. M Klinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Klinger, M. (2017). A role for macromolecular crowding in off-target binding of therapeutic antibodies. Protein Engineering Design and Selection. 30(7). 489–494. 5 indexed citations

Zemlin, Michael, M Klinger, Jason M. Link, et al.. (2003). Expressed Murine and Human CDR-H3 Intervals of Equal Length Exhibit Distinct Repertoires that Differ in their Amino Acid Composition and Predicted Range of Structures. Journal of Molecular Biology. 334(4). 733–749. 267 indexed citations

Barker, Thomas H., M Klinger, Dale S. Feldman, Gerald M. Fuller, & James S. Hagood. (2001). Spectrophotometric Analysis for Determining the Average Number of Poly(ethylene) Glycol Molecules on PEGylated Proteins Utilizing a Protein Digestion Step. Analytical Biochemistry. 290(2). 382–385. 5 indexed citations

Barker, Thomas H., Gerald M. Fuller, M Klinger, Dale S. Feldman, & James S. Hagood. (2001). Modification of fibrinogen with poly(ethylene glycol) and its effects on fibrin clot characteristics. Journal of Biomedical Materials Research. 56(4). 529–535. 32 indexed citations

Russlies, Martin, et al.. (1998). Erythrocytes and Proinflammatory Mediators in Wound Drainage. Vox Sanguinis. 75(3). 205–211. 4 indexed citations

Russlies, Martin, et al.. (1998). Erythrocytes and Proinflammatory Mediators in Wound Drainage. Vox Sanguinis. 75(3). 205–211. 5 indexed citations

Klinger, M, et al.. (1997). Different erythrocyte and platelet surface electric charge in various types of glomerulonephritis. Nephrology Dialysis Transplantation. 12(4). 707–712. 3 indexed citations

Klinger, M & J. Peter Gergen. (1993). Regulation of runt transcription by Drosophila segmentation genes. Mechanisms of Development. 43(1). 3–19. 123 indexed citations

Klinger, M & Dennis J. McCarthy. (1992). Enzymatic synthesis and properties of uridine-5-′-O-(2-thiodiphosphoglucuronate). Bioorganic & Medicinal Chemistry Letters. 2(2). 197–200. 2 indexed citations

10.

Klinger, M, et al.. (1990). Activity of Type 1 Erythrocyte Complement Receptors in Uremia and after Renal Transplantation. The International Journal of Artificial Organs. 13(10). 658–662.

11.

Ekborg, Göran, et al.. (1987). Synthesis of 3-O-?-d-xylopyranosyl-l-serine (xylosylserine) andO-?-d-galactopyranosyl-(1-4)-O-?-d-xylopyranosyl-l-serine (galactosylxylosylserine) and use of the synthetic products for detection of galactosyltransferase I activity in rat liver. Glycoconjugate Journal. 4(3). 255–266. 7 indexed citations

12.

Klinger, M, et al.. (1983). Lymphocyte function in patients with chronic glomerulonephritis. International Urology and Nephrology. 15(1). 83–92. 1 indexed citations

13.

Klinger, M, et al.. (1983). Aldolase and adenosine deaminase activity in lymphocytes of patients with glomerulonephritis. International Urology and Nephrology. 15(3). 273–279. 3 indexed citations

14.

Morton, Phillip A., M Klinger, & Sheldon M. Steiner. (1982). Characterization of an amino acid fucoside of normal and SV40-transformed human embryonic lung cells.. PubMed. 42(8). 3022–7. 4 indexed citations

15.

Klinger, M, Roger A. Laine, & Sheldon M. Steiner. (1981). Characterization of novel amino acid fucosides.. Journal of Biological Chemistry. 256(15). 7932–7935. 23 indexed citations

16.

Klinger, M. (1980). Response of lymphocytes to nonspecific mitogens (PHA, Con A, PWM) in patients with glomerulonephritis.. PubMed. 28(2). 225–40. 2 indexed citations

17.

Klinger, M, et al.. (1980). The influence of uremic sera on the blastic transformation of lymphocytes of healthy subjects, stimulated with non-specific mitogens (PHA, con A, PWM).. PubMed. 28(1). 73–82. 2 indexed citations

18.

Klinger, M, et al.. (1978). Subpopulations of T and B lymphocytes in peripheral blood and lymphocytes reactivity to non-specific mitogens (PHA, Con A, PWM) in in vitro cultures in patients suffering from in vitro cultures in patients suffering from glomerulonephritis.. PubMed. 26(1-6). 289–94. 2 indexed citations

19.

Larriba, Germán, M Klinger, Stephen J. Sramek, & Sheldon M. Steiner. (1977). Novel fucose-containing components from rat tissues. Biochemical and Biophysical Research Communications. 77(1). 79–85. 8 indexed citations

20.

Klinger, M, et al.. (1975). Blastic transformation of lymphocytes in in vitro cultures during immunosuppressive therapy in patients with glomerulonephritis.. PubMed. 23(3). 367–78. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact